Literature DB >> 2445718

Monoclonal antibody 1a3 recognizes a monomorphic epitope unique to DQ molecules.

L Shookster1, T Matsuyama, G Burmester, R Winchester.   

Abstract

Monoclonal antibody 1a3 reacts with a unique monomorphic epitope present only on DQ molecules as determined by immunoprecipitation, two-dimensional gel analysis and partial N-terminal amino acid sequencing. This monomorphic epitope is found on DQ molecules of all homozygous B lymphoblastoid cell lines tested, including those that type as either DQw1, DQw2, DQw3, or DQ "blank." Analysis of the predicted secondary structure of class II molecules indicates that the regions most likely to constitute an antigenic determinant are variable in DQ molecules, possibly accounting for the rarity of antibodies to monomorphic DQ epitopes.

Mesh:

Substances:

Year:  1987        PMID: 2445718     DOI: 10.1016/0198-8859(87)90006-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

1.  Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells.

Authors:  D M Altmann; J M Heyes; H Ikeda; A M Sadler; D Wilkinson; J A Madrigal; J G Bodmer; J Trowsdale
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 2.  The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis.

Authors:  R J Winchester; P K Gregersen
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Twenty-six DR beta and 16 DQ beta chain IEF variants and their associated HLA-DR, HLA-DQ, and HLA-Dw specificities.

Authors:  S Rodriguez de Cordoba; P Marshall; P Rubinstein
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads.

Authors:  Shirly Naveh; Yftah Tal-Gan; Song Ling; Amnon Hoffman; Joseph Holoshitz; Chaim Gilon
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

5.  Idiotypic diversity and variable region gene usage by mouse anti-HLA-DQ3 mAb.

Authors:  Y Iwasaki; H Takabatake; M Monestier; S Ferrone
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Induction of multinucleated giant cells from rheumatoid arthritis (RA) synovial adherent cells by anti-DR antibody.

Authors:  T Matsuyama; N Nakashima; T Matsuda; H Nakamura; S Uchida; T Abe
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

7.  Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.

Authors:  Tieying Hou; Cornelia H Rinderknecht; Andreas V Hadjinicolaou; Robert Busch; Elizabeth Mellins
Journal:  Methods Mol Biol       Date:  2013

8.  Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis.

Authors:  Sanja Glisic; Parthav Jailwala
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

9.  CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.

Authors:  Caitlin E Egan; Dessislava Stefanova; Adnan Ahmed; Vijay J Raja; Jessica W Thiesmeyer; Kevin J Chen; Jacques A Greenberg; Taotao Zhang; Bing He; Brendan M Finnerty; Rasa Zarnegar; Moonsoo M Jin; Theresa Scognamiglio; Noah Dephoure; Thomas Fahey; Irene M Min
Journal:  Thyroid       Date:  2021-07-05       Impact factor: 6.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.